Bonus episode: Randy Baron updates $AMRS and $RNLX
Yet Another Value Podcast
Equity Raising
The company has a run rate of one billion dollars, which is about eight times the value of biosants. Once it stops growing more to 50 %, that would then come down t about eight times. But still, it is rough numbers. Billing revenue, ten x divided by 400, forty million shares, ye get 20 plus dollars a share on a stock to day trading at four dollars. This simbilorous story was actually the story ten years ago, when oil was a hundred dllars barrel with no end in sight.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
